SLC7A11 and breast cancer: Subsequently, MDA-MB-231, MCF7, and SKBR3 BC cells were treated with GluOC, and it was demonstrated that the expression levels of SLC7A11 and SLC38A1 in MDA-MB-231 cells were elevated.